Related references
Note: Only part of the references are listed.Effects of soluble cobalt and cobalt incorporated into calcium phosphate layers on osteoclast differentiation and activation
Somying Patntirapong et al.
BIOMATERIALS (2009)
Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis
Mark A. Scheper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells
Fraser P. Coxon et al.
BONE (2008)
Osteonecrosis of the jaws and bisphosphonate therapy
S. L. Ruggiero et al.
JOURNAL OF DENTAL RESEARCH (2007)
Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates
D. B. Kimmel
JOURNAL OF DENTAL RESEARCH (2007)
Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
Ian R. Reid et al.
BONE (2007)
A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: Prevalence, risk factors, and clinical characteristics
Michael Pazianas et al.
CLINICAL THERAPEUTICS (2007)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Bisphosphonates: Mode of action and pharmacology
R. Graham G. Russell
PEDIATRICS (2007)
Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease
Colin R. Dunstan et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts
Vera de Fatima Padrao Correia et al.
DENTAL TRAUMATOLOGY (2006)
Molecular mechanisms of action of bisphosphonates: Current status
Anke J. Roelofs et al.
CLINICAL CANCER RESEARCH (2006)
Structure of periodontal tissues in health and disease
A Nanci et al.
PERIODONTOLOGY 2000 (2006)
Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro
A Schindeler et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer
D Melisi et al.
ENDOCRINE-RELATED CANCER (2005)
In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts
M Kellinsalmi et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
Pharmacokinetics/pharmacodynamics of bisphosphonates - Use for optimisation of intermittent therapy for osteoporosis
SCLM Cremers et al.
CLINICAL PHARMACOKINETICS (2005)
Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells
JC Dumon et al.
EUROPEAN UROLOGY (2004)
Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases
TL Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Bisphosphonates induce apoptosis in human breast cancer cell lines
SG Senaratne et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
